Catheter including arcuate transition region

Information

  • Patent Grant
  • 9492634
  • Patent Number
    9,492,634
  • Date Filed
    Monday, April 2, 2007
    17 years ago
  • Date Issued
    Tuesday, November 15, 2016
    8 years ago
Abstract
A catheter, with one or more lumens, having a first portion and a second portion and an arcuate transition region extending between the first portion and the second portion. The first portion is nonparallel to the second portion.
Description
BACKGROUND

Embodiments described herein are related to a catheter suitable for insertion into a vein of a patient. A catheter is a conduit or tube that is inserted into a body cavity, duct or blood vessel. Catheters may be used for various processes in which bodily fluids, medicaments, or other solutions are introduced and removed from the body, such as perfusion, infusion, apheresis, hemodialysis, chemotherapy, or other processes known in the art.


SUMMARY

In one embodiment, a catheter includes a catheter body extending between a distal end and a proximal end and defining at least one lumen, a first portion and a second portion, and an arcuate transition region extending between the first portion and the second portion, such that the arcuate transition region is configured to be at or near an insertion site into the body of a patient, the arcuate transition region including an exterior angle greater than 180 degrees.


In another embodiment, a catheter includes a catheter body extending between a distal end and a proximal end and defining two lumens, a first portion and a second portion, and an arcuate transition region extending between the first portion and the second portion; wherein at least a majority of the first portion is configured to be disposed outside the body of a patient and, wherein at least a segment of the second portion has a length suitable for insertion inside the body of the patient, and wherein the exterior angle between a central axis of the first portion and a central axis of the second portion is greater than 180 degrees.


In another embodiment, a catheter includes a catheter body extending between a distal end and a proximal end and defining at least two lumens, a first portion and a second portion, and an arcuate transition region extending between the first portion and the second portion, wherein the arcuate transition region includes an exterior angle greater than 180 degrees, at least one transformation region between the first portion and the second portion within which the position of a septum dividing the two lumens at least partially changes, and a separation angle formed between a central axis of the first portion and a central axis of the second portion, wherein the separation angle is no more than about 90 degrees.





BRIEF DESCRIPTION OF THE DRAWINGS

Understanding that drawings depict only typical embodiments of the disclosure and are not therefore to be considered to be limiting of its scope, the present embodiments will be described and explained with additional specificity and detail through the use of the accompanying drawings as listed below.



FIG. 1 shows a perspective view of one embodiment of a catheter including an arcuate transition region.



FIG. 2 shows a bottom elevation view of the catheter shown in FIG. 1.



FIG. 3 shows a side view of the catheter shown in FIGS. 1 and 2.



FIG. 4 shows a perspective view of the arcuate transition region of the catheter shown in FIGS. 1-3.



FIG. 5 shows another embodiment of a catheter including an arcuate transition region.



FIG. 6 shows a top elevation view of the catheter shown in FIG. 5.



FIG. 7 shows a cross-sectional view of the catheter shown in FIGS. 5 and 6.



FIG. 8 shows a top elevation view of one embodiment of a catheter including at least one transformation region.



FIGS. 9-11 show different cross-sectional views of one embodiment of the catheter shown in FIG. 8.



FIGS. 12 and 13 show different cross-sectional views of another embodiment of the catheter shown in FIG. 8.



FIG. 14 shows a top elevation view of one embodiment of a catheter including a plurality of transformation regions.



FIGS. 15-19 show different cross-sectional views of one embodiment of the catheter shown in FIG. 14.



FIG. 20 shows one embodiment of a catheter including an arcuate transition region and at least one transformation region.



FIG. 21 shows a top elevation view of the catheter shown in FIG. 20.



FIG. 22 shows a top elevation view of another embodiment of a catheter according to the instant disclosure.



FIG. 23 shows a top elevation view of a further embodiment of a catheter according to the instant disclosure.





DETAILED DESCRIPTION OF THE EXEMPLARY EMBODIMENTS

Generally, one aspect of the instant disclosure relates to a catheter including an arcuate transition region. Another aspect of the instant disclosure relates to a transformation region within which an orientation of at least one lumen comprising the catheter changes. In addition, a catheter including an arcuate transition region and/or at least one transformation region may include at least one proximal connection structure for facilitating fluid communication with an associated lumen of the catheter and at least one distal leg or portion.


The relative term “distal” refers to those portions of a catheter and those portions of components of the catheter that are nearer, relatively, to an insertion end of the catheter, that is, the end of the catheter that is inserted into an area of a patient's body, such as a blood vessel. In addition, the relative term “proximal” refers to those portions of a catheter and those portions of components of the catheter that are farther, relatively, from the insertion end of the catheter. In one aspect of the instant disclosure, a distal portion of the catheter may cross over or intersect with a proximal portion of the catheter. In addition, optionally, a selected exterior angle may be formed between a central axis of a first portion of the catheter and a central axis of a second portion of the catheter.


As mentioned above, one aspect of the instant disclosure relates to a catheter including an arcuate transition region. Such a catheter may be used for various processes in which bodily fluids, medicaments, or other solutions are introduced and removed from the body, such as perfusion, infusion, apheresis, hemodialysis, chemotherapy, or other processes known in the art. For example, a catheter may be utilized for a hemodialysis catheterization, such as the internal jugular vein catheterization. However, it should be understood by one skilled in the art based on this disclosure, that a catheter can be structured (e.g., increasing or decreasing the catheter size and/or shape, changing a number of lumens defined by the catheter, selecting materials comprising a catheter, etc.) such that the catheter can be beneficially used for a selected medical application in which fluids are introduced and/or removed from the body.


For example, FIG. 1 shows a perspective view of one embodiment of a catheter 10 encompassed by the instant disclosure. As shown in FIG. 1, the catheter 10 extends between a distal end 50 for insertion into a patient and a proximal end 51. As known in the art, optionally, catheter 10 may include a stabilizing cuff affixed to an outer portion of the body of the catheter at a selected longitudinal position such that the cuff will be ultimately positioned within a subcutaneous tunnel formed in the patient. The catheter 10 may also optionally include a hub structure 20 and a clamp device 19. In one embodiment, as discussed in greater detail below, proximal end 51 may include a connector 12 configured for connection to a device used to introduce or remove fluid from at least one lumen of the catheter 10. In further detail, catheter 10 comprises a catheter body including a first portion 70, a second portion 80, and an arcuate transition region 90 extending between the first portion 70 and the second portion 80.


In one embodiment, the arcuate transition region 90 is configured to be at or near an insertion site into the body of a patient. The arcuate transition region 90 near the insertion site indicates that it is located at a position adjacent or close to the location where the catheter enters the body of a patient. The arcuate transition region near the insertion site can be located adjacent to the insertion site on either the interior of the body or the exterior of the body. For example, in one exemplary embodiment the arcuate transition region near the insertion site may be disposed within the body at a location within 5 cm of the insertion site. One having skill in the art would appreciate that “near the insertion site” is a relative term and may depend, in part, on the size of the arcuate region and the catheter used.


In one embodiment, at least a majority of the first portion 70 is configured to be disposed outside the body of a patient and at least a segment of the second portion 70 has a length suitable for insertion inside the body of the patient. In yet another embodiment, the distal end 50 may include a non-helical terminus. In one embodiment, catheter 10 may comprise one or more lumens.


Generally, the instant disclosure contemplates that arcuate transition region 90 may be structured so that first portion 70 is nonparallel with respect to second portion 80. FIG. 2 shows a bottom elevation view of catheter 10 that shows first portion 70 in relation to second portion 80. More particularly, as shown in FIG. 2, a selected exterior angle may be formed between the first portion 70 and the second portion 80, when the catheter 10 is in a substantially unstressed state.


In one embodiment, an exterior angle formed between the first portion 70 and the second portion 80 may exceed 180°. For example, the angle formed between the first portion 70 and the second portion 80 may range from approximately 180-190°, 190-200°, 200-210°, 210-220°, 220-230°, 230-240°, 240-250°, 250-260°, and 260-270°. In yet another embodiment, an exterior angle formed between the first portion 70 and the second portion 80 may be less than 180°. For example, the angle formed between the first portion 70 and the second portion 80 may range from approximately 0-10°, 10-20°, 20-30°, 30-40°, 40-50°, 50-60°, 60-70°, 70-80°, 80-90°, 100-110°, 110-120°, 120-130°, 130-140°, 140-150°, 150-160°, 160-170°, and 170-180°. More particularly, an exterior angle between the first portion 70 and the second portion 80 may be about 225°.


The instant disclosure generally contemplates, without limitation, that the exterior angle may be measured between any surfaces of the first portion 70 and/or the second portion 80. Variations (i.e., increases or decreases) in the magnitude of a measurement of an exterior angle due to a thickness or size of the first portion 70 and/or the second portion 80 are encompassed by the above-discussed exterior angle embodiments. One of ordinary skill in the art will appreciate that at least a portion of arcuate transition region 90 may form a generally circular arc. The instant disclosure further contemplates that, in other embodiments, at least a portion of arcuate transition region 90 may comprise at least one of the following: a generally elliptical arc, a generally parabolic curve, and a generally concave curve.


In one embodiment, an exterior angle may be measured between a central axis of the first portion 70 and a central axis of the second portion 80. For example, angle θ is shown in FIG. 2 extending between a central axis 63 extending along first portion 70 (e.g., along a centroid of a cross-sectional area of the first portion 70) and a central axis 41 extending along second portion 80 (e.g., along a centroid of a cross-sectional area of the second portion 80). Thus, a selected angle θ may be formed between central axis 63 of first portion 70 and central axis 41 of second portion 80, when arcuate transition portion 90 of catheter 10 is in a substantially unstressed state. In one embodiment, as shown in FIG. 2, exterior angle θ may exceed 180°. In one embodiment, exterior angle θ may be about 225°. Further, central axis 63 may cross or intersect with central axis 41 (e.g., for a given reference plane, as shown in the exemplary bottom elevation view of FIG. 2).


In addition, the instant disclosure also contemplates that, optionally, an arcuate transition region of a catheter may form a separation angle between a first portion of a catheter and a second portion of a catheter that are connected by an arcuate transition region. More specifically, FIG. 3 shows a side view of the catheter 10 shown in FIGS. 1 and 2, wherein a separation angle λ is formed generally between first portion 70 and second portion 80 of catheter 10. In one embodiment, separation angle λ may be no more than about 90°. More specifically, separation angle λ may be approximately 10° or less.


One of ordinary skill in the art will appreciate that a catheter including an arcuate transition region may include one or both of a selected exterior angle and a selected separation angle. Put another way, an exterior angle and a separation angle may be employed in combination or may be employed separately, without limitation. One of ordinary skill in the art will appreciate that, in one embodiment of a catheter comprising both a separation angle and an exterior angle, at least a portion of arcuate transition region 90 may be substantially helical. FIG. 4 shows a perspective view of arcuate transition region 90, wherein arcuate transition region 90 is substantially helical.


Such a configuration may provide a catheter that is more comfortable and easier to secure to a patient. Additionally or optionally, such a unique shape may act to stabilize the catheter within the tunnel/venotomy region and may prevent pistoning and migration of the catheter prior to tissue ingrowth. Since the transition or path from tunnel track into vein is generally three dimensional and tortuous in nature such a catheter including an arcuate transition region may contour more closely to this transition or path.


In further detail, an arcuate transition region may be capable of handling even relatively tight curves. For example, the catheter can be more easily “rolled” by the doctor prior to placement to adjust where the distal end will end up. As a further note, the catheter may comprise a material (e.g., polyurethane) that significantly softens at body temperature. Thus, in one embodiment, the shape of the catheter may not generate residual stresses (i.e., outward forces) exceeding forces generated by a conventional (e.g., U-shaped) catheters. Conventional catheters are disclosed in U.S. Pat. No. 5,509,897 to Twardowski et al.


In another embodiment, a catheter may comprise a catheter body extending between a distal end and a proximal end and defining a plurality of lumens. Further, the distal end may comprise a plurality of distal end regions that extend generally from a junction region of the catheter body. In addition, the proximal end may comprise a plurality of proximal extension legs. In general, the instant disclosure contemplates, as discussed above, that such a catheter may include an arcuate transition region extending between the first portion and the second portion of the catheter.


For example, FIGS. 5 and 6 show a perspective view and a top elevation view, respectively, of a catheter 110 including distal end regions 132 and 134 (generally at a distal end 150 of the catheter 110) and proximal extension legs 108 and 106 (generally at a proximal end 151 of the catheter). Further, catheter 110 may include a proximal connection structure comprising a proximal end 151 of catheter 110. More particularly, couplings 112 and 114 may each comprise a luer-lock type coupling or other threaded or releasable fluid coupling structure as known in the art. As shown in FIG. 6, the hub structure 120 and proximal extension legs 108 and 106 may be suitably configured to establish a selected separation between the couplings 112 and 114 of proximal extension legs 108 and 106. Such a configuration may facilitate coupling of the catheter 110 to a fluid conveying or processing device, (e.g., dialysis equipment). As known in the art, hub structure 120 may facilitate fluid connection between proximal extension legs 108 and 106 and respective lumens defined by catheter 110. Further, the hub structure 120, as shown in FIGS. 5 and 6 may optionally include suture wings 121, which may be used to suture the catheter 110 to the patient for positioning of the catheter 110 after insertion into the patient.


Optionally, at least one of distal end regions 132 and 134 as well as one or more of proximal extension legs 108 and 106 and/or one or more of couplings 112 and 114, may include a visual or palpable indicator (e.g., a marking, a color, a symbol, a raised or indented feature, etc.) to indicate correspondence upon connection of catheter 110 to a fluid moving device. Also, each of proximal extension legs 108 and 106 may optionally include a clamp device, such as clamp devices 119 and 117, for clamping one or both of the proximal extension legs 108 and 106 when the catheter 110 is not connected to a fluid conveying device or when fluid flow through one or both of proximal extension legs 108 and 106 is not desired.


As shown in FIGS. 5 and 6, catheter 110 comprises a first portion 170, a second portion 180, and an arcuate transition region 190 extending between the first portion 170 and the second portion 180. Catheter 110 may comprise two lumens, wherein each of the lumens extends between one of proximal extension legs 106 or 108 and an associated one of distal end regions 132 or 134. More particularly, catheter 110 may include a first distal end region 132 and a second distal end region 134, each extending distally from a junction region 154. As shown in FIGS. 5 and 6, the second distal end region 134 may be shorter in length (e.g., measured from junction region 154) than a length (e.g., measured from junction region 154) of the first distal end region 132.


One of ordinary skill in the art will understand that proximal extension legs 106 and 108 in combination with couplings 112 and 114, respectively, may be used to connect catheter 110 to a fluid processing or fluid moving device (e.g., a medicine pump, a dialysis machine, etc.). Further, one of ordinary skill in the art will also understand that the first distal end region 132 may be used to remove fluid from a patient (e.g., as a venous extension leg in a hemodialysis application) and second distal end region 134 may be used to introduce fluid into a patient (e.g., as an arterial extension leg in a hemodialysis application). Additionally, the instant disclosure contemplates that the second distal end region 134 may be used to remove fluid from a patient (e.g., as a venous extension leg in a hemodialysis application) and first distal end region 132 may be used to introduce fluid into a patient (e.g., as an arterial extension leg in a hemodialysis application), if desired, without limitation.


The instant disclosure contemplates that arcuate transition region 190 may be configured, as discussed above in relation to any feature or aspect discussed above relative to arcuate transition region 90. Particularly, arcuate transition region 190 may be structured so that a first portion 170 is nonparallel with respect to a second portion 180.



FIG. 6 shows a top elevation view of catheter 110 that shows a selected exterior angle may be formed generally between the first portion 170 and the second portion 180, when the catheter 110 is in a substantially unstressed state. In one embodiment, an exterior angle formed between the first portion 170 and the second portion 180 may exceed 180°. In another embodiment, an exterior angle may be about 225°.


In one embodiment, an exterior angle formed between the first portion 170 and the second portion 180 may exceed 180°. For example, the angle formed between the first portion 170 and the second portion 180 may range from approximately 180-190°, 190-200°, 200-210°, 210-220°, 220-230°, 230-240°, 240-250°, 250-260°, and 260-270°. In yet another embodiment, an exterior angle formed between the first portion 170 and the second portion 180 may be less than 180°. For example, the angle formed between the first portion 170 and the second portion 180 may range from approximately 0-10°, 10-20°, 20-30°, 30-40°, 40-50°, 50-60°, 60-70°, 70-80°, 80-90°, 100-110°, 110-120°, 120-130°, 130-140°, 140-150°, 150-160°, 160-170°, and 170-180°. More particularly, an exterior angle between the first portion 170 and the second portion 180 may be about 225°. Further, one of ordinary skill in the art will appreciate that at least a portion of arcuate transition region 190 may comprise at least one of the following: a substantially circular arc, an elliptical arc, a parabolic curve, and a concave curve.


In addition, the instant disclosure generally contemplates, without limitation, that an exterior angle may be measured between any surfaces of the first portion 170 and/or the second portion 180, and such an exterior angle encompasses variations (i.e., increases or decreases) in the magnitude of the exterior angle due to a thickness or size of the first portion 170 and/or the second portion 180.


In one embodiment, an exterior angle may be measured between a central axis of the first portion 170 and a central axis of the second portion 180. For example, exterior angle θ is shown in FIG. 6 extending between a central axis 163 extending along first portion 170 (e.g., along a centroid of a cross-sectional area of the first portion 170) and a central axis 141 extending along the second portion 180 (e.g., along a centroid of a cross-sectional area of the second portion 180). Thus, a selected exterior angle θ may be formed between central axis 163 of first portion 170 and central axis 141 of second portion 180, when arcuate transition portion 190 is in a substantially unstressed state.


In one embodiment, exterior angle θ may exceed 180°. In another embodiment, exterior angle θ may be about 225°. Further, central axis 163 may cross or intersect with central axis 141 (e.g., for a given reference plane, as shown in the exemplary bottom elevation view of FIG. 6). In addition, arcuate transition region 190 of catheter 110 may form a separation angle (as discussed above relative to catheter 10) measured between first portion 170 and second portion 180 of catheter 110. In one embodiment, such a separation angle may be from approximately 0-90°. More particularly, a separation angle may be about 10° or less. Further, one of ordinary skill in the art will appreciate that a catheter including an arcuate transition region, in one embodiment, may comprise both a separation angle and an exterior angle. For example, in one embodiment, at least a portion of arcuate transition region 190 may be substantially helical.


Optionally, the first distal end region 132 may include one or more apertures formed through the first distal end region 132 in fluid communication with a lumen of catheter 110. Similarly, the second distal end region 134 may include one or more apertures in fluid communication with a lumen of catheter 110. Such one or more apertures formed through one or both first distal end region 132 and second distal end region 134 may facilitate fluid flow into or from the distal end regions 132 and 134.



FIG. 7 shows a cross-sectional view of the catheter shown in FIG. 6, taken along reference line 7-7. Direction V, as shown in FIG. 7, denotes the direction from which catheter 110 is viewed in FIG. 6. As shown in FIG. 7, the portion of catheter 110 extending generally between hub structure 120 and junction region 154 may include two lumens, such as lumens 202 and 204, exhibiting a generally semicircular (e.g., a generally D-shaped) cross-sectional shape. In one embodiment, a septum 205 may comprise a membrane extending (e.g., diametrically) across a generally circular tube or lumen. In one embodiment, the cross-sectional shape shown in FIG. 7 may extend along catheter 110 substantially uniformly (i.e., substantially unchanging in orientation) along the length of catheter 110 between hub structure 120 and junction region 154. One of ordinary skill in the art will appreciate that the shape and cross-section configuration of any of the lumens of the catheter or extension legs may be varied, and, thus, the scope of the instant disclosure should not be limited to the above-described embodiments.


In another aspect of the instant disclosure, an orientation of a lumen may change along the length of at least a portion of a catheter. For example, a catheter may include at least one region within which an orientation of a lumen changes. Particularly, FIG. 8 shows a top elevation view of a catheter 111. In one embodiment, catheter 111, as shown in FIG. 8, may comprise a curved region 230. In other embodiments, catheter 111 may comprise an arcuate transition region as previously described, or may be substantially straight or linear, if desired. In addition, catheter 111 may include a proximal connection structure comprising a proximal end 151 including couplings 112 and 114 as described previously with respect to FIG. 6. Thus, hub structure 120 and extension legs 108 and 106 may be configured to establish a selected separation between the couplings 112 and 114 of proximal extension legs 108 and 106. Hub structure 120 may facilitate fluid connection between proximal extension legs 108 and 106 and respective lumens defined by catheter 111. Also, each of proximal extension legs 108 and 106 may optionally include a clamp device, such as clamp devices 119 and 117.


Further, catheter 111 may include a transformation region 220, within which an orientation of a lumen at least partially changes. More particularly, FIGS. 9-11 show cross-sectional views of catheter 111, taken at reference lines 9-9, 10-10, and 11-11, respectively. More specifically, FIGS. 9-11 show lumens 202 and 204 and septum 205. Direction V, as shown in FIGS. 9-11, denotes the direction from which catheter 111 is viewed in FIG. 8. In one embodiment, lumens 202 and 204, as shown in FIG. 8, may be generally unchanged between hub structure 120 and transformation region 220. Also, in one embodiment, lumens 202 and 204, as shown in FIG. 11, may be generally unchanged between transformation region 220 and junction region 154. As shown in FIG. 8, a coupler 222 may optionally operably connect transformation region 220 to an adjacent portion of catheter 111. Such a configuration may ease manufacturing of catheter 111.


Within transformation region 220, the orientation of lumens 202 and 204 may change between respective orientations shown in FIGS. 9 and 11. More specifically, as shown in FIG. 10, lumens 202 and 204 (and septum 205) may be rotated in a counter-clockwise (CCW) direction with reference to a distal direction along catheter 111 within transformation region 220. In other words, the position of the septum 205 may at least partially change within transformation region 220. In one embodiment, septum 205 may smoothly and continuously rotate along a distal direction within catheter 111, such as in a screw or twist transformation, wherein the angle of rotation is proportional to the distal translation at any position within transformation region 220. Lumens 202 and 204 as well as septum 205 may be otherwise transformed, abruptly or gradually, between the cross section shown in FIG. 9 and the cross section shown in FIG. 11, without limitation.


In another embodiment, lumens 202 and 204, and septum 205, may rotate in a clockwise direction relative to a distal direction within transformation region 220 between the orientations shown in FIGS. 9 and 11. More specifically, as shown in FIG. 12, lumens 202 and 204, and septum 205, may be rotated in a clockwise direction (CW) with reference to a distal direction along catheter 111 within transformation region 220. In one embodiment, septum 205 may smoothly and continuously rotate along a distal direction within catheter 111, such as in a screw or twist transformation, wherein the angle of rotation is proportional to the distal translation at any position within transformation region 220. In one embodiment, the relative difference in the position of septum 205 shown in FIG. 9 and the position of septum 205 shown in FIG. 11 may be about 90°. In other embodiments, a difference in position of septum 205 may be any selected angle, such as an angle up to about 360°, or greater than 360°, without limitation.


A catheter including at least one transformation region may exhibit at least one selected mechanical property (e.g., a flexibility, moment of inertia, strength, etc.). Also, one of ordinary skill in the art will appreciate that position of septum 205, as shown in FIG. 11 or FIG. 13, may be beneficial for resisting kinking and/or reducing the cross-sectional area of a selected region of the catheter. In one embodiment, septum 205 may be aligned with a plane of bending, such as a plane in which bending deflections occur. Thus, in one embodiment, a neutral axis of the septum during bending may lie within a cross-sectional area of the septum, similar to a web of an I-beam in pure bending. One of ordinary skill in the art will understand that in such a configuration, a moment of inertia of the septum may be generally maximized with respect to bending in the plane of bending. Thus, septum 205 may resist bending, and reduce deflection or deformation of the catheter 111, to a degree exceeding an identical septum oriented transverse to a plane of bending or otherwise oriented. Such a configuration may inhibit deformation of the catheter 111 and may resist deformation that causes one or more of lumens 202 and 204 to become smaller in cross-sectional area.


In a further embodiment, a catheter may include a plurality of transformation regions. For example, FIGS. 14-19 show a perspective view and several cross-sectional views of a catheter 101 including transformation regions 220 and 240. Generally, catheter 101 may be as described previously in relation to catheter 111. More particularly, within transformation region 220, lumens 202 and 204 may generally rotate clockwise, shown as CW in FIG. 16, between the orientation shown in FIG. 15 and the orientation shown in FIG. 17 (i.e., about 90°). In addition, catheter 101 further includes transformation region 240. As shown in FIGS. 18 and 19, lumens 202 and 204 of catheter 101 may generally rotate counter-clockwise, shown as CCW in FIG. 18, within region 240, between the orientation shown in FIG. 17 and the orientation shown in FIG. 19 (i.e., about 90°). Thus, proximal extension leg 106 may be in fluid communication with second distal end region 134 via lumen 202. Further, proximal extension leg 108 may be in fluid communication with first distal end region 132 via lumen 204. The instant disclosure contemplates that a catheter including at least one transformation region may include any lumen configuration, such as one or more lumens exhibiting a selected size and shape as known in the art, without limitation.


The instant disclosure further encompasses any combination of features or attributes described above. For example, in one embodiment, a catheter may include an arcuate transition region and at least one transformation region. More particularly, FIGS. 20 and 21 show a perspective view and a top elevation view of catheter 301, which includes arcuate transition region 190 as well as transformation regions 220 and 240. In one embodiment, transformation region 220 may comprise lumens 202 and 204 as shown in FIGS. 15-17. More specifically, lumens 202 and 204 may rotate within transformation region 220 between the orientation shown in FIG. 15 and the orientation shown in FIG. 17 (e.g., about 90°). Further, in one embodiment, transformation region 240 may include lumens 202 and 204 as shown in FIGS. 17-19. Particularly, lumens 202 and 204 may rotate within transformation region 240 between the orientation shown in FIG. 17 and the orientation shown in FIG. 19 (e.g., about 90°). Accordingly, proximal extension leg 106 may be in fluid communication with second distal end region 134 via lumen 202 and proximal extension leg 108 may be in fluid communication with first distal end region 132 via lumen 204.


While aspects of the instant disclosure are described in relation to one embodiment of a catheter comprising two lumens, the instant disclosure is not so limited and other embodiments and catheter configurations are encompassed by the instant disclosure. For example, a catheter defining a plurality of lumens may comprise a plurality of substantially concentric tubes of varying diameter. In a further embodiment, a catheter may comprise three (or more) lumens. Generally, any lumen configuration known in the art may be utilized in combination with at least one of the following: an arcuate transition region and at least one transformation region. In addition, any distal tip structure as known in the art may comprise a catheter including at least one of the following: an arcuate transition region and at least one transformation region.


For example, any distal tip structure, such as a so-called “stepped-tip,” “split-tip,” or any catheter distal tip structure as known in the art, without limitation, may be included by a catheter comprising at least one of the following: an arcuate transition region and at least one transformation region. For example, in one embodiment, a catheter may include a so-called “stepped tip.” More particularly, FIG. 22 shows a catheter 303, which generally comprises components as described with respect to FIGS. 5 and 6. However, catheter 303 included a distal tip structure 250 including an extending end region 232 and a recessed region 235. As known in the art, an aperture 237 may be formed to communicate with at least one of the lumens of catheter 303. Thus, FIGS. 21 and 22 show respective catheters 301 and 303 comprising different distal tip configurations.


In a further aspect of the instant disclosure, one of ordinary skill in the art will appreciate that a transition region of a catheter may extend between a first portion and second portion of a catheter in a variety of ways. For instance, by way of illustration, FIG. 22 shows an arcuate transition region 190 extending from first portion 170, in a generally clockwise direction, toward second portion 180. In another embodiment, FIG. 23 shows a catheter 305, which generally comprises components as described with respect to FIG. 22, wherein an arcuate transition region 190 extends from first portion 170, in a generally counter-clockwise direction, toward second portion 180.


Without further elaboration, it is believed that one skilled in the art can use the preceding description to utilize the present disclosure to its fullest extent. The examples and embodiments disclosed herein are to be construed as merely illustrative and not a limitation of the scope of the present disclosure in any way. It will be apparent to those having skill in the art that changes may be made to the details of the above-described embodiments without departing from the underlying principles of the disclosure described herein. In other words, various modifications and improvements of the embodiments specifically disclosed in the description above are within the scope of the appended claims.

Claims
  • 1. A catheter comprising: a catheter body extending between a distal end and a proximal end and defining at least one lumen, the catheter body including: a first straight portion, a second straight portion, and an arcuate transition region extending in a continuous helical curve for more than a half revolution between the first straight portion and the second straight portion, the first straight portion crossing the second straight portion for a given reference plane, the arcuate transition region positioned at or near an insertion site into a body of a patient during catheter use.
  • 2. The catheter of claim 1, wherein the helical curve of the arcuate transition region traverses about 225°.
  • 3. The catheter of claim 1, wherein a separation angle between 0° and 90° is formed between a central axis of the first portion and a central axis of the second portion.
  • 4. The catheter of claim 1, wherein the catheter body defines at least two lumens.
  • 5. The catheter of claim 4, wherein the distal end of the catheter body comprises a venous extension leg including a first lumen, and an arterial extension leg including a second lumen.
  • 6. The catheter of claim 4, wherein the first straight portion and the second straight portion are separated by at least one transformation region within which a position of a septum dividing the at least two lumens at least partially changes.
  • 7. The catheter of claim 6, wherein the position of the septum changes in a clockwise direction relative to a distal direction along the catheter.
  • 8. The catheter of claim 6, wherein the position of the septum changes in a counter-clockwise direction relative to a distal direction along the catheter.
  • 9. The catheter of claim 6, wherein the position of the septum changes up to about 360°.
  • 10. The catheter of claim 1, wherein the proximal end of the catheter body comprises at least one connector.
  • 11. The catheter of claim 10, wherein the proximal end of the catheter body comprises a first connector including a first lumen, and a second connector including a second lumen.
  • 12. The catheter of claim 1, wherein at least a majority of the first straight portion is configured to be disposed outside the body of the patient and, wherein at least a segment of the second straight portion has a length suitable for insertion inside the body of the patient.
  • 13. A catheter comprising: a catheter body extending between a catheter body first end and a catheter body second end and defining two lumens in a Cartesian x-y-z coordinate system, the catheter body including: a first portion extending from the catheter body second end along an x-axis in a positive direction to a first end of an arcuate transition region and a second portion extending from a second end of the arcuate transition region in a negative x and negative y direction to the catheter body first end, the arcuate transition region connecting the first portion to the second portion;wherein, during use, at least a majority of the first portion is disposed outside of a body of a patient and, wherein at least a segment of the second portion has a length suitable for insertion inside the body of the patient; andwherein an exterior arc angle between a central axis of the first portion and a central axis of the second portion is greater than 180° when the arcuate transition region is in a substantially unstressed state such that the first portion and the second portion have a common (x,y) coordinate point not at the catheter body first end or catheter body second end when a z axis of the x-y-z coordinate system is oriented parallel to a longitudinal axis of the arcuate transition region such that the arcuate transition region curls around the longitudinal axis.
  • 14. The catheter of claim 13, wherein the catheter body first end includes a non-helical terminus.
  • 15. The catheter of claim 13, wherein the first portion and the second portion are separated by at least one transformation region within which a position of a septum dividing the at least two lumens at least partially changes.
  • 16. The catheter of claim 13, wherein a separation angle between 0° and 90° is formed between the central axis of the first portion and the central axis of the second portion in the z-direction.
  • 17. The catheter of claim 13, wherein the exterior arc angle is about 225°.
CROSS-REFERENCE TO RELATED APPLICATION

This application claims the benefit of U.S. Provisional Application No. 60/744,094, entitled “CATHETER INCLUDING ARCUATE TRANSITION REGION AND/OR AT LEAST ONE TRANSFORMATION REGION,” filed Mar. 31, 2006, which is incorporated herein by reference in its entirety.

US Referenced Citations (354)
Number Name Date Kind
256590 Pfarre Apr 1882 A
2175726 Gebauer Oct 1939 A
2590895 Scarpellino Apr 1952 A
2910981 Wilson et al. Nov 1959 A
3055361 Ballard Sep 1962 A
3256885 Higgins et al. Jun 1966 A
3434691 Hamilton Mar 1969 A
3612038 Halligan Oct 1971 A
3634924 Blake et al. Jan 1972 A
3677243 Nerz Jul 1972 A
3720210 Diettrich Mar 1973 A
3812851 Rodriguez May 1974 A
3890977 Wilson Jun 1975 A
3921631 Thompson Nov 1975 A
3935857 Co Feb 1976 A
3942528 Loeser Mar 1976 A
3964488 Ring et al. Jun 1976 A
3983203 Corbett Sep 1976 A
4016879 Mellor Apr 1977 A
4020829 Willson et al. May 1977 A
4027659 Slingluff Jun 1977 A
4027668 Dunn Jun 1977 A
4033331 Guss et al. Jul 1977 A
4079737 Miller Mar 1978 A
4099528 Sorenson et al. Jul 1978 A
4117836 Erikson et al. Oct 1978 A
4134402 Mahurkar Jan 1979 A
4180068 Jacobsen et al. Dec 1979 A
4202332 Tersteegen et al. May 1980 A
4203436 Grimsrud May 1980 A
4217895 Sagae et al. Aug 1980 A
4220813 Kyle Sep 1980 A
4220814 Kyle et al. Sep 1980 A
4250880 Gordon Feb 1981 A
4270535 Bogue et al. Jun 1981 A
4292976 Banka Oct 1981 A
4300550 Gandi et al. Nov 1981 A
4306562 Osborne Dec 1981 A
4311152 Modes et al. Jan 1982 A
4352354 Ujihara et al. Oct 1982 A
4352951 Kyle Oct 1982 A
4385631 Uthmann et al. May 1983 A
4392855 Oreopoulos et al. Jul 1983 A
4402685 Buhler et al. Sep 1983 A
4403983 Edelman et al. Sep 1983 A
4405313 Sisley et al. Sep 1983 A
4417888 Cosentino et al. Nov 1983 A
D272651 Mahurkar Feb 1984 S
4451252 Martin et al. May 1984 A
4451256 Weikl et al. May 1984 A
4471778 Toye Sep 1984 A
4493696 Uldall et al. Jan 1985 A
4508535 Joh et al. Apr 1985 A
4531933 Norton et al. Jul 1985 A
4543087 Sommercorn et al. Sep 1985 A
4549879 Groshong et al. Oct 1985 A
4557261 Rugheimer et al. Dec 1985 A
4563180 Jervis et al. Jan 1986 A
4568329 Mahurkar Feb 1986 A
4568338 Todd Feb 1986 A
4576199 Svensson et al. Mar 1986 A
4581012 Brown et al. Apr 1986 A
4583968 Mahurkar Apr 1986 A
4595005 Jinotti Jun 1986 A
4596559 Fleischhacker Jun 1986 A
4619643 Bai et al. Oct 1986 A
4623327 Mahurkar Nov 1986 A
4626240 Edelman et al. Dec 1986 A
4643711 Bates Feb 1987 A
4648868 Hardwick et al. Mar 1987 A
4668221 Luther May 1987 A
4671796 Groshong et al. Jun 1987 A
4675004 Hadford et al. Jun 1987 A
4681564 Landreneau Jul 1987 A
4681570 Dalton Jul 1987 A
4682978 Martin et al. Jul 1987 A
4687471 Twardowski et al. Aug 1987 A
4687741 Farrell et al. Aug 1987 A
4692141 Mahurkar Sep 1987 A
4694838 Wijayarthna et al. Sep 1987 A
4701159 Brown et al. Oct 1987 A
4701166 Groshong et al. Oct 1987 A
4735620 Ruiz Apr 1988 A
4738667 Galloway Apr 1988 A
4739768 Engelson Apr 1988 A
4772268 Bates Sep 1988 A
4772269 Twardowski et al. Sep 1988 A
4773431 Lodomirski Sep 1988 A
4784639 Patel Nov 1988 A
4789000 Aslanian Dec 1988 A
4790809 Kuntz Dec 1988 A
4795439 Guest Jan 1989 A
4808155 Mahurkar Feb 1989 A
4808156 Dean Feb 1989 A
4820349 Saab Apr 1989 A
4822345 Danforth Apr 1989 A
4834709 Banning et al. May 1989 A
4842582 Mahurkar Jun 1989 A
4846814 Ruiz Jul 1989 A
4867742 Calderon Sep 1989 A
4883058 Ruiz Nov 1989 A
4895561 Mahurkar Jan 1990 A
4898669 Tesio et al. Feb 1990 A
4909787 Danforth Mar 1990 A
4935004 Cruz Jun 1990 A
4961731 Bodicky et al. Oct 1990 A
4961809 Martin et al. Oct 1990 A
4973306 Ruiz Nov 1990 A
4976703 Franetzki et al. Dec 1990 A
4981477 Schon et al. Jan 1991 A
4985014 Orejola Jan 1991 A
5016640 Ruiz May 1991 A
5041083 Tsuchida et al. Aug 1991 A
5041107 Heil, Jr. Aug 1991 A
5045072 Castillo et al. Sep 1991 A
5053003 Dadson et al. Oct 1991 A
5053004 Markel et al. Oct 1991 A
5053023 Martin et al. Oct 1991 A
5057073 Martin et al. Oct 1991 A
5058595 Kern Oct 1991 A
5084024 Skinner Jan 1992 A
5098413 Trudell et al. Mar 1992 A
5141499 Zappacosta Aug 1992 A
5156592 Martin et al. Oct 1992 A
5171216 Dasse et al. Dec 1992 A
5171227 Twardowski et al. Dec 1992 A
5188619 Myers Feb 1993 A
5197951 Mahurkar Mar 1993 A
5209723 Twardowski et al. May 1993 A
5221255 Mahurkar et al. Jun 1993 A
5221256 Mahurkar Jun 1993 A
5292305 Boudewijn et al. Mar 1994 A
5306263 Voda Apr 1994 A
5318588 Horzewski et al. Jun 1994 A
5324274 Martin et al. Jun 1994 A
5327905 Avitall Jul 1994 A
5346471 Raulerson Sep 1994 A
5350358 Martin Sep 1994 A
5354271 Voda Oct 1994 A
5354297 Avitall Oct 1994 A
5358479 Wilson Oct 1994 A
5358493 Schweich, Jr. et al. Oct 1994 A
5374245 Mahurkar Dec 1994 A
5380276 Miller et al. Jan 1995 A
5395316 Martin et al. Mar 1995 A
5401258 Voda Mar 1995 A
5403291 Abrahamson Apr 1995 A
5405320 Twardowski et al. Apr 1995 A
5405341 Martin et al. Apr 1995 A
5445625 Voda Aug 1995 A
5507995 Schweich, Jr. et al. Apr 1996 A
5509897 Twardowski et al. Apr 1996 A
5509902 Raulerson Apr 1996 A
5569182 Twardowski et al. Oct 1996 A
5569197 Helmus et al. Oct 1996 A
5569218 Berg Oct 1996 A
5599311 Raulerson Feb 1997 A
5624413 Markel et al. Apr 1997 A
5650759 Hittman et al. Jul 1997 A
5685867 Twardowski et al. Nov 1997 A
5718678 Fleming, III Feb 1998 A
5718692 Schon et al. Feb 1998 A
5741233 Riddle et al. Apr 1998 A
5755760 Maguire et al. May 1998 A
5776111 Tesio et al. Jul 1998 A
5795326 Siman Aug 1998 A
5830184 Basta Nov 1998 A
5830196 Hicks Nov 1998 A
5868700 Voda Feb 1999 A
5885259 Berg Mar 1999 A
5897537 Berg et al. Apr 1999 A
5902282 Balbierz May 1999 A
5941872 Berg Aug 1999 A
5944732 Raulerson et al. Aug 1999 A
5947953 Ash et al. Sep 1999 A
5957961 Maguire et al. Sep 1999 A
5961486 Twardowski et al. Oct 1999 A
5968009 Siman Oct 1999 A
5989206 Prosl et al. Nov 1999 A
5989213 Maginot Nov 1999 A
6001079 Pourchez et al. Dec 1999 A
6002955 Willems et al. Dec 1999 A
6004280 Buck et al. Dec 1999 A
6024693 Schock et al. Feb 2000 A
6033382 Basta Mar 2000 A
6083213 Voda Jul 2000 A
6156016 Maginot Dec 2000 A
6190349 Ash et al. Feb 2001 B1
6190371 Maginot et al. Feb 2001 B1
6277100 Raulerson et al. Aug 2001 B1
6280423 Davey et al. Aug 2001 B1
6293927 McGuckin, Jr. Sep 2001 B1
6342120 Basta Jan 2002 B1
6356790 Maguire et al. Mar 2002 B1
6475195 Voda Nov 2002 B1
6475207 Maginot et al. Nov 2002 B1
6533763 Schneiter Mar 2003 B1
6551281 Raulerson et al. Apr 2003 B1
6585705 Maginot et al. Jul 2003 B1
6595966 Davey et al. Jul 2003 B2
6595983 Voda Jul 2003 B2
6620118 Prosl et al. Sep 2003 B1
6638242 Wilson et al. Oct 2003 B2
6682519 Schon Jan 2004 B1
6695832 Schon et al. Feb 2004 B2
6719749 Schweikert et al. Apr 2004 B1
6723084 Maginot et al. Apr 2004 B1
D489452 Schweikert May 2004 S
6730096 Basta May 2004 B2
D491265 Schweikert Jun 2004 S
6743218 Maginot et al. Jun 2004 B2
6749580 Work et al. Jun 2004 B2
6796991 Nardeo Sep 2004 B2
D498299 Schweikert Nov 2004 S
6814718 McGuckin, Jr. et al. Nov 2004 B2
6823617 Schweikert Nov 2004 B2
6858019 McGuckin et al. Feb 2005 B2
6881211 Schweikert et al. Apr 2005 B2
D505202 Chesnin May 2005 S
6911014 Wentling et al. Jun 2005 B2
6916051 Fisher Jul 2005 B2
6926669 Stewart et al. Aug 2005 B1
6926721 Basta Aug 2005 B2
6939328 Raulerson Sep 2005 B2
6969381 Voorhees Nov 2005 B2
6986752 McGuckin, Jr. et al. Jan 2006 B2
6991625 Gately et al. Jan 2006 B1
D515211 Chesnin Feb 2006 S
7008412 Maginot Mar 2006 B2
7011645 McGuckin, Jr. et al. Mar 2006 B2
7018374 Schon et al. Mar 2006 B2
7066925 Gately et al. Jun 2006 B2
D525359 Stephens Jul 2006 S
7074213 McGuckin, Jr. et al. Jul 2006 B2
7077829 McGuckin, Jr. et al. Jul 2006 B2
D530420 Chesnin Oct 2006 S
7115134 Chambers Oct 2006 B2
7163531 Seese et al. Jan 2007 B2
7172571 Moskowitz et al. Feb 2007 B2
7220246 Raulerson et al. May 2007 B2
7223263 Seno May 2007 B1
D544600 Wentling Jun 2007 S
D546446 Chesnin Jul 2007 S
7261708 Raulerson Aug 2007 B2
7393339 Zawacki et al. Jul 2008 B2
7494478 Itou et al. Feb 2009 B2
7695450 Twardowski et al. Apr 2010 B1
7799013 Gandras Sep 2010 B2
7867218 Voda Jan 2011 B1
7976518 Shaughnessy et al. Jul 2011 B2
8021321 Zawacki Sep 2011 B2
8029457 Ash et al. Oct 2011 B2
8066660 Gregersen et al. Nov 2011 B2
8092415 Moehle Jan 2012 B2
8152951 Zawacki et al. Apr 2012 B2
8206371 Nimkar et al. Jun 2012 B2
8292841 Gregersen Oct 2012 B2
8323227 Hamatake et al. Dec 2012 B2
8409191 Avitall et al. Apr 2013 B2
8500939 Nimkar et al. Aug 2013 B2
8540661 Gregersen Sep 2013 B2
8597275 Nimkar et al. Dec 2013 B2
8696614 Gregersen et al. Apr 2014 B2
8808227 Zawacki et al. Aug 2014 B2
8827943 Angheloiu et al. Sep 2014 B2
8876754 Ranchod et al. Nov 2014 B2
8894601 Moehle et al. Nov 2014 B2
8992454 Anand Mar 2015 B2
9126011 Ash et al. Sep 2015 B2
9131956 Shaughnessy et al. Sep 2015 B2
9155860 Ash et al. Oct 2015 B2
9174019 Gregersen Nov 2015 B2
9233200 Gregersen et al. Jan 2016 B2
20020032411 Basta Mar 2002 A1
20020091362 Maginot et al. Jul 2002 A1
20030036698 Kohler et al. Feb 2003 A1
20030066218 Schweikert Apr 2003 A1
20030093027 McGuckin et al. May 2003 A1
20030093029 McGuckin et al. May 2003 A1
20030114832 Kohler et al. Jun 2003 A1
20030144623 Heath et al. Jul 2003 A1
20040015151 Chambers Jan 2004 A1
20040034324 Seese et al. Feb 2004 A1
20040034333 Seese et al. Feb 2004 A1
20040054321 Schon et al. Mar 2004 A1
20040059314 Schon et al. Mar 2004 A1
20040075198 Schweikert et al. Apr 2004 A1
20040092863 Raulerson et al. May 2004 A1
20040097903 Raulerson May 2004 A1
20040122416 Schweikert et al. Jun 2004 A1
20040186461 DiMatteo Sep 2004 A1
20040193098 Wentling et al. Sep 2004 A1
20040195131 Spolidoro Oct 2004 A1
20040249349 Wentling Dec 2004 A1
20050000844 Schweikert Jan 2005 A1
20050015007 Itou et al. Jan 2005 A1
20050038453 Raulerson Feb 2005 A1
20050043684 Basta et al. Feb 2005 A1
20050049572 Schweikert et al. Mar 2005 A1
20050049628 Schweikert et al. Mar 2005 A1
20050054990 Graft et al. Mar 2005 A1
20050085765 Voorhees Apr 2005 A1
20050096580 Moskowitz et al. May 2005 A1
20050096585 Schon et al. May 2005 A1
20050096609 Maginot et al. May 2005 A1
20050101903 Kohler et al. May 2005 A1
20050107770 Schweikert et al. May 2005 A1
20050113801 Gandras May 2005 A1
20050120523 Schweikert Jun 2005 A1
20050124970 Kunin et al. Jun 2005 A1
20050137527 Kunin Jun 2005 A1
20050137580 Raulerson et al. Jun 2005 A1
20050192545 Voorhees et al. Sep 2005 A1
20050209583 Powers et al. Sep 2005 A1
20050222593 Markel et al. Oct 2005 A1
20050234369 Voorhees Oct 2005 A1
20050245900 Ash Nov 2005 A1
20050261665 Voorhees Nov 2005 A1
20060004316 Difiore et al. Jan 2006 A1
20060004324 Ruddell et al. Jan 2006 A1
20060015072 Raulerson Jan 2006 A1
20060015130 Voorhees et al. Jan 2006 A1
20060030827 Raulerson et al. Feb 2006 A1
20060047267 Gately et al. Mar 2006 A1
20060047268 Stephens Mar 2006 A1
20060064072 Gately et al. Mar 2006 A1
20060095030 Avitall et al. May 2006 A1
20060095062 Stephens May 2006 A1
20060184142 Schon et al. Aug 2006 A1
20060189959 Schneiter Aug 2006 A1
20060200111 Moehle et al. Sep 2006 A1
20060206094 Chesnin et al. Sep 2006 A1
20060253063 Schweikert Nov 2006 A1
20060271012 Canaud et al. Nov 2006 A1
20070043307 Raulerson et al. Feb 2007 A1
20070049960 Stephens et al. Mar 2007 A1
20070060866 Raulerson et al. Mar 2007 A1
20070073271 Brucker et al. Mar 2007 A1
20070135794 Raulerson et al. Jun 2007 A1
20070198047 Schon et al. Aug 2007 A1
20070219510 Zinn et al. Sep 2007 A1
20070225661 Ash et al. Sep 2007 A1
20070225682 Ash et al. Sep 2007 A1
20070225683 Raulerson et al. Sep 2007 A1
20070225684 Wentling et al. Sep 2007 A1
20070233017 Zinn et al. Oct 2007 A1
20070233018 Bizup et al. Oct 2007 A1
20080021417 Zawacki et al. Jan 2008 A1
20080039774 Zawacki et al. Feb 2008 A1
20080045886 Hobbs et al. Feb 2008 A1
20080045894 Perchik et al. Feb 2008 A1
20080097339 Ranchod et al. Apr 2008 A1
20090018493 Ash et al. Jan 2009 A1
20140200524 Wiley et al. Jul 2014 A1
Foreign Referenced Citations (33)
Number Date Country
1092927 Jan 1981 CA
1150122 Jul 1983 CA
545218 Feb 1932 DE
2627850 Jan 1977 DE
2627851 Jan 1977 DE
3736226 May 1989 DE
146777 Oct 1977 DK
0036642 Sep 1981 EP
0081724 Jun 1983 EP
0102342 Mar 1984 EP
0132344 Jan 1985 EP
0242985 Oct 1987 EP
256478 Feb 1988 EP
0263645 Apr 1988 EP
323738 Jul 1989 EP
0386408 Sep 1990 EP
386408 Sep 1990 EP
2069287 Jun 1993 ES
2529083 Dec 1983 FR
2238724 Jun 1991 GB
59034265 Feb 1984 JP
63111833 May 1988 JP
1058263 Mar 1989 JP
1238872 Sep 1989 JP
WO 9115255 Oct 1991 WO
WO-9212754 Aug 1992 WO
WO 9321983 Nov 1993 WO
9624399 Aug 1996 WO
9717102 May 1997 WO
0023137 Apr 2000 WO
0213899 Feb 2002 WO
WO 0230489 Apr 2002 WO
03030960 Apr 2003 WO
Non-Patent Literature Citations (110)
Entry
PCT Written Opinion of the International Searching Authority; International Application No. PCT/US20074/008148. European Patent Office.
Vas-Cath; Niagara, Dual Lumen Catheter Instructions for Use; Jun. 1997; Canada.
Vas-Cath; Opti-Flow and Soft-Cell; Dual Lumen Catheter Straight and Pre-Curved (PC) Catheters, with and without VitaCuff; Jun. 16, 1997.
Bard Access Systems; Power Picc The Universal Picc, Polyurethane PICC with Safety Excalibur Introducer System Instructions for Use; Jul. 2003.
Bard Access Systems; PowerPicc, The Universal Picc, Polyurethane Radiology Catheters with Microintroducer Set Instructions for Use; Nov. 2003.
Bard; 135cm Guidewire, Instructions for Use; Mar. 2002, excerpt.
Bard Access Systems; HemoSplit Long-Term Hemodialysis Catheter, Instructions for Use; Apr. 2003.
McIntosh, Berry, Thompson, and Durham; Double Lumen Catheter for Use with Artificial Kidney; J.A.M.A.; Feb. 21, 1959; 137/835-138/836.
Medcomp; Effective Solutions for Vascular Access; Product Line; Apr. 2006; Rev. D.
Cournand et al. “Double Lumen Catheter for Intravenous and Intracardiac Blood Sampling and Pressure Recording.” Proceedings of the Society for Experimental Biology and Medicine, vol. 60, pp. 73, 1994.
Cook Critical Care; Cook TPN Pre-Cut Double Lumen Catheters with Off-Set Tips; A000053 1982.
Raja et al. “Comparison of Double Lumen Subclavian with Single Lumen Catheter—One Year Experience.” Trans American Society of Artificial Internal Organs, vol. XXX 1984.
Zuniga et al. “Hemodialisis: Accesso Vascular Con Cateter De Doble Lumen.” Rev. Med. Chile; 117: pp. 991-996, 1989.
Vanherweghem et al. “Complications Related to Subclavian Catheters for Hemodialysis.” American Journal of Nephrol 6, pp. 339-345, 1986.
Lally et al. “Use of Subclavian Venous Catheter for Short- and Long-term Hemodialysis in Children.” Journal of Pediatric Surgery, vol. 44, No. 7, pp. 603-605, 1987.
Cheesbrough et al. “A Prospective Study of the Mechanisms of Infection Associated with Hemodialysis Catheters.” The Journal of Infectious Diseases vol. 154, No. 4, pp. 579-589, 1986.
Ota et al. “A Completely New Poly(ether-urethane) Graft Ideal for Hemodialysis Blood Access.” Trans Am Soc Artif Intern Organs, vol. XXXIII, pp. 129-135, 1987.
Scribner et al. “Evolution of the Technique of Home Parenteral Nutrition.” Journal of Parenteral and Enteral Nutrition. vol. 3, No. 2, pp. 58-61, 1979.
Sanders et al. “Experience with Double Lumen Right Atrial Catheters.” American Society of Parenteral and Enteral Nutrition, vol. 6, No. 2., pp. 95-99, 1982.
Shiley ©; Subclavian Cannulae product brochure, 1986.
Hickman, Robert O., et al., “A Review of Hemodialysis Catheters and Access Devices.” Dialysis & Transplantation, vol. 16, No. 9, pp. 481 485, 1997.
Annest, Lon S et al. “Use of a Split-Sheath Vein Introducer for Subclavian Venipuncture in the Placement of Silicone Catheters for Chronic Venous Access.” The American Journal of Surgery, vol. 144, pp. 367-369, 1982.
McDowell, Donald E., et al., “A Simplified technique for percutaneous insertion of permanenet vascular access catheters in patients requiring chronic hemodialysis.” Section of Vascular Surgery, Department of Surgery, West Virginia University Medical Center, Morgantown, WV 26505.
Sims, Terran W., et al., “Successful Utilization of Subclavian Catheters for Hemodialysis and Apheresis Access”, AANNT Journal, vol. 10, No. 6, 1993.
Uldall, P.R., et al., “A Subclavian Cannula for Temporary Vascular Access for Hemodialysis of Plasmapheresis.” Dialysis & Transplantation, vol. 8, No. 10, p. 963, 1979.
Carbone, Vera, “Hemodialysis Using the PermCath Double Lumen Catheter.” ANNA Journal, vol. 15, No. 3, pp. 171-173, 1988.
Bregman, Harold, et al., “Minimum Performance Standards for Double-Lumen Subclavian Cannulas for Hemodialysis.” vol. 32, No. 1, 1986.
Vas-Cath; Soft-cell Permanent Dual Lumen Cannula with Dacron Cuff; Product details; 1988.
Vas-Cath; Instructions for use of Soft-cell Permanent Dual Lumen Catheter; May 25, 1998.
Saklayen, “Letters to the editor re: prolonged use of a Subclavian Catheter for Hemodialysis.” Dialysis & Transplantation, Apr. 1998.
Quinton Instrument Co; Descriptions and Instructions for use of PermCath HemoCath Dual Lumen Catheter; 1984.
Vas-Cath; Permanent Dual Lumen Catheter for Vas-Cath; Advertisement; Contemporary Dialysis and Nephrology, May 1988.
Vas-Cath; The Vas-Cath Advantage: Temporary and Permanent Dual Lumen Catheters, Flexxicon® & Flexxicon® Blue brochure.
Vas-Cath; Temporary Vascular Access Products; Product Line; 1985.
Shiley; Subclavian Cannulae; Aug. 1986.
Medcomp; Hemodialysis Products; Product line.
Impra; Dual Lumen Subclavian Catheter; Information.
Cook Incorporated; Subclavian Double Lumen Hemodialysis Sets and Trays; U.S. Pat. No. 4,306,562.
Vas-Cath; Catheter Repair Kit CRK-1 with Titanium Replacement Connector; 1988.
Vas-Cath; Peritoneal Dialysis Catheters; Indications for use; 1988.
Vas-Cath; Instructions for use of Flexxicon Dual Lumen Catheters (DLC), Kits (DLK), Trays (DLT); 1988.
Vas-Cath; Vaccess 2000 Series Single Lumen Subclavian Cannulas (Central Venous Access/Hemodialysis). Brochure distributed by Vas-Cath.
Vas-Cath; Vaccess 2000 Series Single Lumen Subclavian Cannulas (Single Needle Hemodialysis); 1984.
Vas-Cath; Vaccess 1000 Series Single Lumen Femoral Cannulas (Hemodialysis); 1984.
Vas-Cath; For acute dialysis . . . Vas-Cath is accessible; Advertistement; 1987.
Vas-Cath; Flexxicon Dual Lumen Catheters. Instructions for Use distributed by Vas-Cath.
Quinton Instrument Company; Peritoneal Dialysis and Hemodialysis; Catalog.
Aubaniac, Robert. “L'injection intraveineuse sous-claviculaire: Avantages et technique.” La Presse Medicale. 1952.
Cimochowski, George E., et al., “Superiority of the Internal Jugular over teh Subclavian Access for Temporary Dialysis.” Nephron, vol. 54, No. 2, 1990.
Duffy, B. J. “The Clinical Use of Polyethylene Tubing for Intravenous Therapy.” Annals of Surgery, vol. 136, No. 5, 1949.
Erben, Joseph, et al., “Experience with Routine use of Subclavian Vein Cannulation in Haemodialysis.” Dialysis and Renal Transplantation, vol. 6, 1969.
Hoshal, Verne L., et al., “Fibrin Sleeve Formation on Indwelling Subclavian Central Venous Catheters.” Archives of Surgery, vol. 102, 1971.
Ratcliffe, P.J. et al., “Massive Thrombosis around Subclavian Cannulas Used for Haemodialysis” The Lancet (Letters to the Editor), vol. 1, No. 8287, 1982.
Schillinger, F., et al., “Post Catheterisation Vein Stenosis in Haemodialysis: Comparative Angiographic Study of 50 Subclavian and 50 Internal Jugular Accesses”, Nephrology Dialysis Transplantation, vol. 6, No. 10, 1991.
Shaldon, Stanley, et al., “Hemodialysis by Percutaneous Cathererisation of the Femoral Artery and Vein with Regional Heparinisation.” The Lancet, vol. 2, 1961.
Twardowski, Zbylut J., “Chapter 57: Peritoneal Catheter Placement and Management.” Suki and Massry's Therapy of Renal Diseases and Related Disorders, Third Edition.
Young, Warren, “Chapter 14: Elastic Stability”. Roark's Formulas for Stress Strain 1989.
Vas-Cath; Accessories/Price List for Canadian Hospitals, Hemodialysis Products effecive May 1, 1982.
Vas-Cath; Vaccess 2 Double-Lumen Subclavian Cannula.
Vas-Cath; Single Lumen PTFE SubClavian/Femoral Cannulas, Sc-100; Advertisement.
Vas-Cath; Temporary Vascular Access Products.
Bregman, Harold, et al.,“The Double-Lumen Subclavian Cannula—A Unique Concept in Vascular Access”. Dialysis & Transplantation, vol. 11, No. 12, pp. 1065-1070, 1982.
Vas-Cath; Vaccess 2000: Single Lumen Subclavian Cannulas, Instructions for Use—Central Venous Access.
Vas-Cath; Accessories/Price List.
Peters, Joseph L., et al., “Long-term venous access.” British Journal of Hospital Medicine, 1984.
Berlyne, G.M., “Editorial: Hemodialysis versus the Newer Techniques.” Nephron, vol. 27, No. 1, 1981.
Seldinger, Sven Irar, “Catheter Replacement of the Needle in Percutaneous Arteriography.” Roentgen Diagnostic Department, Karolnska Sjukhuset, Stockholm, Sweden.
Shaldon, Stanley, et al., “New Developments with Artificial Kidney.” British Medical Journal, London, Jun. 29, 1963.
Dialysis & Transplantation (A creative Age Publication); vol. 13, No. 8, Aug. 1984.
Pristave, Robert J., “Medicare Audits.” Dialysis & Transplantation, vol. 12, No. 7, Jul. 1983.
Bricker, Catherine., “Psychosocial Implications of Nutrition Assessment for Adult Chronic Renal Failure Patients.” Dialysis & Transplantation, vol. 11, No. 5, May 1982.
Dialysis & Transplantation (A creative Age Publication); vol. 11 No. 6,Jun. 1982.
Dialysis & Transplantation; vol. 11, No. 7, Jul. 1982.
Dialysis & Transplantation; vol. 11, No. Aug. 1982.
Dialysis & Transplantation; vol. 11, No. 9, Sep. 1982.
Dialysis & Transplantation; vol. 11, No. 11, Nov. 1982.
Dialysis & Transplantation; vol. 11, No. 12, Dec. 1982.
Dialysis & Transplantation; vol. 12, No. 1, Jan. 1983.
Dialysis & Transplantation; vol. 12, No. 2, Feb. 1983.
Dialysis & Transplantation; vol. 12, No. 3, Mar. 1983.
Dialysis & Transplantation; vol. 12, No. 4, Apr. 1983.
Dialysis & Transplantation; vol. 12, No. 5, May 1983.
Dialysis & Transplantation; vol. 12, No. 6, Jun. 1983.
Dialysis & Transplantation; vol. 12, No. 7, Jul. 1983.
Dialysis & Transplantation; vol. 12, No. 8, Aug. 1983.
Dialysis & Transplantation; vol. 12, No. 9, Sep. 1983.
Dialysis & Transplantation; vol. 13, No. 5, May 1984.
Dialysis & Transplantation; vol. 13, No. 6, Jun. 1984.
Dialysis & Transplantation; vol. 13, No. 7, Jul. 1984.
Dialysis & Transplantation; vol. 13, No. 9, Sep. 1984.
Dialysis & Transplantation; vol. 13, No. 10, Oct. 1984.
Dialysis & Transplantation; vol. 14, No. 3, Mar. 1985.
Dialysis & Transplantation; vol. 14, No. 5, May 1985.
Dialysis & Transplantation; vol. 13, No. 8, Aug. 1984.
Dialysis & Transplantation; vol. 17, No. 6, Jun. 1988.
Dunn, John, et al., “Centra venous dialysis access: Experience with a dual-lumen, silicone rubber catheter.” Surgery, vol. 102, No. 5, Nov. 1987.
Twardowski, Zbylut J., “The Need for a ‘Swan-Neck’ Permantently Bent Arcuate Peritoneal Dialysis Catheter.” Peritoneal Dialysis Bulletin, Oct.-Dec. 1985.
Vas-Cath; Soft-Cell Permanent Dual Lumen Catheter; Insertion Guide.
Quinton; PermCath and Pediatric PermCath Catheters; Instructions for Use.
Netter, Frank H.; A compilation of Paintings on the Normal and Pathologic Anatomy and Physiology, Embryology, and Diseases of the Heart; The Ciba Collection of Medical Illustrations, vol. 5.
Palmer, Russell A., “Treatment of Chronic Renal Failure by Prolonged Peritoneal Dialysis.” The New England Journal of Medicine, vol. 274, No. 5, Feb. 3, 1966.
Palmer, Russell A, et al., “Prolonged Peritoneal Dialysis for Chronic Renal Failure,” The Lancet, Mar. 28, 1964.
Vas-Cath; Confidential Training Manual and Marketing Support File for Vascular Access Catheters and Accessories for Dialysis; Revised Jan. 1989.
Bard; HemoGlide Long Term Hemodialysis Catheter. Instructions for Use for HemoGlide Straight and Precurved (PC) Catheters, with and without VitaCuff © Antimicrobial Cuff, 2002.
Vas-Cath; Vaccess 2000: Single Lumen Subclavian Cannulas, Instructions for Use—Single Needle Hemodialysis.
Vas-Cath, “Uldall™ SC-100 Means Quality” Advertisement, 1980.
Shiley © “Major Improvement. Major Advantage. Shiley's All-Silicone Subclavian Cannual.” Brochure, 1980.
Vas-Cath, “Go for the Jugular” temporary catheter product advertisement, 1994.
Quinton et al. “Eight Months' Experience with Silastic-Teflon Bybass Cannulas,” Department of Medicine and Surgery, Universityof Washington and the Quinton Instrument Company, 1961.
PCT/US2007/008148 filed Apr. 2, 2007 Search Report dated Aug. 28, 2007.
Related Publications (1)
Number Date Country
20070233042 A1 Oct 2007 US
Provisional Applications (1)
Number Date Country
60744094 Mar 2006 US